日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mitochondrial complex I deficiency induces Alzheimer's disease-like signatures that are reversible by targeted therapy

线粒体复合物 I 缺乏会诱发类似阿尔茨海默病的特征,而这些特征可通过靶向治疗逆转。

Gao, Huanyao; Jensen, Kate; Nesbitt, Jarred; Ostroot, Mark; Cary, Gregory A; Wiley, Jesse; Trushin, Sergey; Watzlawik, Jens O; Springer, Wolfdieter; Galkin, Alexander; Baloni, Priyanka; Funk, Cory; Trushina, Eugenia

Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's disease

在阿尔茨海默病体外和体内模型中对一种新型线粒体复合物I抑制剂进行治疗评估

Sergey Trushin ,Thi Kim Oanh Nguyen ,Andrea Stojakovic ,Mark Ostroot ,J Trey Deason ,Su-Youne Chang ,Liang Zhang ,Slobodan I Macura ,Toshihiko Nambara ,Wenyan Lu ,Takahisa Kanekiyo ,Eugenia Trushina

Examining Medicare Reimbursement Differences for Cochlear Implant Surgery

分析医疗保险对人工耳蜗植入手术的报销差异

Ali, Layla; Salib, Samuel; Hazzard, Iyawnna; Howard, Julia; Ostroot, Cameron; Salem, Ahmed; Isaacs, Richard S

Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's disease.

在阿尔茨海默病体外和体内模型中对一种新型线粒体复合物 I 抑制剂进行治疗评估

Trushin Sergey, Nguyen Thi Kim Oanh, Stojacovic Andrea, Ostroot Mark, Deason J Trey, Chang Su-Youne, Zhang Liang, Macura Slobodan I, Nambara Toshihiko, Lu Wenyan, Kanekiyo Takahisa, Trushina Eugenia

Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice

部分抑制线粒体复合物 I 可减少 3xTg-AD 小鼠的 Tau 病理并改善能量稳态和突触功能

Andrea Stojakovic, Su-Youne Chang, Jarred Nesbitt, Nicholas P Pichurin, Mark A Ostroot, Tomonori Aikawa, Takahisa Kanekiyo, Eugenia Trushina